Webinar
15 Nov 2022

Container Closure Integrity Testing - Deterministic Methods

Container closure integrity (CCI) testing is determined by evaluating whether a given container maintains its sterile barrier. It is a mandatory step in the design verification phase of a drug – device combination product development. Several methods exist with different advantages and limitations.

During this session, we will address the following points:

  • Probabilistic vs deterministic CCI Testing.
  • Presentation of the different deterministic CCI testing methods with applications and limitations.
  • What to consider when selecting CCI testing method.


  • At the end of the session, attendees should better understand the influence of the drug specificities to select the most suitable technical option for Container Closure Integrity testing activities based on the advantages and limitations of different techniques available on the market.

    Content provided by our supplier

    Zebrasci

    • US
    • 2022
      On CPHI since
    • 1
      Certificates
    • 1 - 24
      Employees
    Company types
    Contract Service
    Primary activities
    Laboratory Services

    Other Content from Zebrasci (1)

    • Webinar Container Closure Integrity (CCI) Testing

      In this webinar, originally broadcast as part of the Pharmapack Europe show, Robert Schultheis, Founder & Chief Technology Officer, ZebraSci discusses: Probabilistic vs deterministic CCI Testing Presentation of the different deterministic CCI testing methods with applications and limitations What to consider when selecting CCI testing method In this session the audience will benefit from understanding the influence of the drug specificities to select the most suitable technical option for Container Closure Integrity testing activitiesbased on the advantages and limitations of different techniques available on the market